# Stoke Therapeutics, Inc.: Form 8-K, filed Dec 6, 2024

- Company: [Stoke Therapeutics, Inc.](/companies/stok.md) (CIK 1623526)
- Form: 8-K
- Filed: 2024-12-06
- Accepted by EDGAR: Dec 6, 2024, 17:19 ET
- Period: 2024-12-04
- Accession: 0001193125-24-272559
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1623526/000119312524272559/d916273d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1623526/000119312524272559/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1623526/000119312524272559/d916273d8k.htm

Filed Dec 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-272559. Last ingested by Listed: Nov 14, 2026, 21:52 ET. No prices; not investment advice.
